͵ÅÄ͵¿ú

Blotter

Science-related legislation to watch

One bill would provide $26 billion in emergency funding for agencies that support research; another would protect against foreign influence in research
Sarina Neote
Aug. 19, 2020

The ͵ÅÄ͵¿ú and ͵ÅÄ͵¿ú Biology’s public affairs team tracks federal legislation that affects the scientific community. Here we report on and respond to two recent bills — one that would provide emergency monies for agencies that fund scientific research and one that would put measures in place to thwart foreign interference in research.

Research Investment to Spark the Economy (RISE) Act

As COVID-19 swept across the nation, academic laboratories and university research centers closed their doors and slowed much of their federally funded research. that a widespread and lengthy shutdown will affect the pace of scientific discovery. Being away from labs for weeks or months would certainly mean having to restart or altogether abandon many experiments, which translates to wasted time and resources.

Some scientists have urged institutions to develop  to sustain research unrelated to COVID-19. Such plans would address both how to restart research projects and how to avoid wasting years of scientific progress.

In response to mounting calls from the scientific community for the federal government to guarantee investments in research unrelated to COVID-10, U.S. House Reps, Diana DeGette, D-Colo., Fred Upton, R-Mich., Eddie Bernice Johnson, D-Texas., Frank Lucas, R-Okla., Anna Eshoo, D-Calif., and Anthony Gonzalez, R-Ohio., introduced the on June 24. The legislation would authorize $26 billion in emergency relief for federal science agencies that support scientists whose work has been affected by the pandemic.

This bill would allow federal science agencies to provide supplemental funding to extend the duration of some grants. This would enable principal investigators to complete research interrupted by COVID-19, extend the training of graduate students or employment of postdoctoral researchers on federal grants, and reconfigure labs and equipment to resume on-site research activities safely.

The RISE Act is an important piece of legislation to ensure that the American research enterprise can restart and continue vital federally funded research. This legislation is necessary to preserve our scientific infrastructure and protect the innovation pipeline.

Read the ASBMB’s full position statement on the RISE Act here.

Photo by on

Safeguarding American Innovation Act

The Senate Committee on Homeland Security and Government Affairs released a report on foreign influence on American research in November. In July, Senate subcommittee Chairman Rob Portman, R-Ohio., and ranking member Top Carper, D-Del., introduced , to thwart bad actors while maintaining transparency and collaboration in the scientific research enterprise.

The legislation would establish a Federal Research Security Council to implement a uniform, machine-readable federal grant-application process, implement a uniform and regular reporting process, and issue guidance to executive agencies to develop compliance and oversight programs.

Some with provisions in the legislation, such as one that would reduce the reporting foreign gifts threshold from $250,000 to $50,000. Both Portman and Carper have to their offices about their concerns. While the committee approved the bill July 22, it’s unclear when it will come up for a vote by the full Senate given how few days the Senate will be in session between now and the November presidential election.

The ASBMB encourages the committee to continue to work on a bipartisan basis and with stakeholders in the scientific community to fully address foreign influence on American research while ensuring the continuation of productive scientific international collaboration.

Read the ASBMB’s full statement on the Safeguarding American Innovation Act here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Sarina Neote

Sarina Neote is ASBMB's director of public affairs.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Policy

Policy highlights or most popular articles

Applied research won’t flourish without basic science
Essay

Applied research won’t flourish without basic science

Oct. 6, 2024

Three senior figures at the US National Institutes of Health explain why the agency remains committed to supporting basic science and research.

ASBMB weighs in on NIH reform proposal
Blotter

ASBMB weighs in on NIH reform proposal

Sept. 25, 2024

The agency must continue to prioritize investigator-initiated, curiosity-driven basic research, society says.

ASBMB seeks feedback on NIH postdoc training questions
Training

ASBMB seeks feedback on NIH postdoc training questions

Sept. 18, 2024

The National Institutes of Health takes steps toward addressing concerns about support caps, a funding mechanism and professional development.

5 growing threats to academic freedom
Essay

5 growing threats to academic freedom

Aug. 18, 2024

From educational gag orders to the decline of tenure-track positions, academic freedom in the United States has been worsening in recent years.

Will Congress revive the China Initiative?
Diversity

Will Congress revive the China Initiative?

Aug. 14, 2024

The 2018 program to counter economic espionage raised fears about anti-Asian discrimination and discouraged researchers.

The sweeping impact of the Supreme Court’s Chevron reversal
News

The sweeping impact of the Supreme Court’s Chevron reversal

Aug. 3, 2024

Repealing the 40-year-old doctrine throws laws on climate, conservation, health, technology and more into doubt.